Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pegylated interferon alpha 2b
DRUG
2 trials
Sponsors
Clinical Research Organization, Dhaka, Bangladesh
, The Wistar Institute
Conditions
Chronic Hepatitis B
HIV-1 Infection
Phase 2
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
Completed
NCT01935089
The Wistar Institute
HIV-1 Infection
Start: 2013-08-07
End: 2016-05-02
Updated: 2023-07-06
Phase 3
NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients
NCT01374308
Clinical Research Organization, Dhaka, Bangladesh
Chronic Hepatitis B
Start: 2011-06-30
End: 2013-12-31
Target: 160
Updated: 2012-12-12
Related Papers
Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption.
2021-10-01
Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial
AIDS Research and Human Retroviruses
2020-12-16
19 citations